将PSMA向放射性药物治疗与免疫治疗相结合
Betül Altunay1, Laura Schäfer1, Agnieszka Morgenroth1
1Department of Nuclear Medicine, University Hospital Aachen, Aachen, Germany.
概括
结合前列腺癌放射性药物治疗 (RPT) 和免疫检查点抑制剂可以克服治疗耐药性. 这种方法旨在改善转移性抵抗割的前列腺癌患者的治疗结果.
科学领域:
- 癌症学
- 放射性药物治疗
- 免疫疗法
背景情况:
- 前列腺癌 (PCa) 治疗包括针对PSMA的放射性药物治疗 (RPT),特别是[177Lu]Lu-PSMA-617,该疗法已在转移性抵抗割的PCa中显示出有效性.
- 然而,抗治疗性和PCa中的免疫抑制性瘤微环境限制了RPT和常规免疫疗法的有效性.
- 结合这些方法提供了增强抗瘤反应的潜在策略.
研究的目的:
- 探讨在前列腺癌中将PSMA向性RPT与免疫检查点抑制剂 (ICI) 结合的科学理由.
- 审查支持这种联合治疗的现有临床前和临床证据.
- 讨论未来的研究方向和临床整合策略.
主要方法:
- 对研究RPT和ICI协同作用的临床前研究的文献综述.
- 分析临床试验数据,评估RPT和ICI联合治疗的安全性和有效性.
- 探索组合潜在益处的免疫机制.
主要成果:
- 临床前数据表明,RPT可以调节瘤微环境,从而可能提高ICI的疗效.
- 早期的临床证据表明,将RPT与ICI结合使用可能会改善转移性抗割PCa患者的治疗结果.
- 针对PD-1/PD-L1的特定免疫检查点抑制剂正在与RPT结合进行研究.
结论:
- 针对PSMA的RPT与免疫检查点阻断的结合是前列腺癌的有希望的治疗策略.
- 需要进一步的临床研究来优化治疗方案,并确认长期的疗效和安全性.
- 这种结合方法有可能克服抗药性机制并改善晚期PCa患者的存活率.
更多相关视频
09:49A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020
10.1K
10:47Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
Published on: February 3, 2015
8.9K
相关概念视频
01:27Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K